Top 50 Pharvision Advisers LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| PK | PARK HOTELS & RESORTS INC | 2.74% | 10.2K | $145K | new | $10.65(+35.19%) | 2026-06-30 | |
| GDOT | GREEN DOT CORP | 2.59% | 10.2K | $138K | new | $12.34(+9.24%) | 2026-06-30 | |
| GO | GROCERY OUTLET HLDG CORP | 2.56% | 13.6K | $136K | new | $8.38(+17.30%) | 2026-06-30 | |
| ADAM | ADAMAS TRUST INC. | 2.38% | 13.5K | $126K | new | $6.60(+54.62%) | 2026-06-30 | |
| CLF | CLEVELAND-CLIFFS INC NEW | 2.33% | 13.2K | $124K | new | $12.74(+0.63%) | 2026-06-30 | |
| CGNT | COGNYTE SOFTWARE LTD | 2.31% | 14.0K | $123K | new | $8.83(+6.58%) | 2026-06-30 | |
| AVAH | AVEANNA HEALTHCARE HLDGS INC | 2.28% | 14.1K | $121K | new | $7.15(+30.39%) | 2026-06-30 | |
| SXC | SUNCOKE ENERGY INC | 2.28% | 15.0K | $121K | new | $9.33(+2.10%) | 2026-06-30 | |
| BLMN | BLOOMIN BRANDS INC | 2.26% | 13.1K | $120K | new | $6.67(+64.77%) | 2026-06-30 | |
| INN | SUMMIT HOTEL PPTYS | 2.16% | 16.3K | $115K | new | $5.29(+17.20%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (6 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | -1.36% |
| Top 20 Holdings Unweighted | — | — | — | — | -1.59% |
Pharvision Advisers LLC reports $5.30M in US-listed equity holdings across 62 positions in its most recent 13F filing. Its largest disclosed positions are PK (2.7%), GDOT (2.6%) and GO (2.6%). The top 20 holdings account for 43.51% of reported assets. Its disclosed equity book has returned -1.36% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Pharvision Advisers LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Pharvision Advisers LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1898824). View Pharvision Advisers LLC’s 13F filings on SEC